HK1182768A1 - 特應性皮炎標記物及其利用技術 - Google Patents

特應性皮炎標記物及其利用技術

Info

Publication number
HK1182768A1
HK1182768A1 HK13110153.7A HK13110153A HK1182768A1 HK 1182768 A1 HK1182768 A1 HK 1182768A1 HK 13110153 A HK13110153 A HK 13110153A HK 1182768 A1 HK1182768 A1 HK 1182768A1
Authority
HK
Hong Kong
Prior art keywords
technique
same
atopic dermatitis
marker
dermatitis marker
Prior art date
Application number
HK13110153.7A
Other languages
English (en)
Inventor
宫田智
宫崎香
安田知永
岩松明彥
池澤善郎
相原道子
森山佳谷乃
Original Assignee
株式會社芳珂
宫崎香
池澤善郎
相原道子
森山佳谷乃
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式會社芳珂, 宫崎香, 池澤善郎, 相原道子, 森山佳谷乃 filed Critical 株式會社芳珂
Publication of HK1182768A1 publication Critical patent/HK1182768A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13110153.7A 2005-10-21 2009-01-23 特應性皮炎標記物及其利用技術 HK1182768A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005306498 2005-10-21

Publications (1)

Publication Number Publication Date
HK1182768A1 true HK1182768A1 (zh) 2013-12-06

Family

ID=37962556

Family Applications (3)

Application Number Title Priority Date Filing Date
HK13110153.7A HK1182768A1 (zh) 2005-10-21 2009-01-23 特應性皮炎標記物及其利用技術
HK13110154.6A HK1182769A1 (zh) 2005-10-21 2009-01-23 特應性皮炎標記物及其利用技術
HK13110155.5A HK1182770A1 (zh) 2005-10-21 2009-01-23 特應性皮炎標記物及其利用技術

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK13110154.6A HK1182769A1 (zh) 2005-10-21 2009-01-23 特應性皮炎標記物及其利用技術
HK13110155.5A HK1182770A1 (zh) 2005-10-21 2009-01-23 特應性皮炎標記物及其利用技術

Country Status (6)

Country Link
US (1) US7820396B2 (zh)
JP (1) JP5282228B2 (zh)
KR (1) KR20080063326A (zh)
CN (5) CN101292032A (zh)
HK (3) HK1182768A1 (zh)
WO (1) WO2007046463A1 (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009066804A1 (en) * 2007-11-20 2009-05-28 Korea Research Institute Of Bioscience And Biotechnology Marker proteins for the diagnosis, therapy and monitoring of atopic dermatitis from human plasma
AU2009246180B2 (en) 2008-05-14 2015-11-05 Dermtech International Diagnosis of melanoma and solar lentigo by nucleic acid analysis
KR101109043B1 (ko) * 2008-12-30 2012-02-09 사회복지법인 삼성생명공익재단 각질세포 또는 혈청 유래의 아토피성 피부질환 마커
JP5750646B2 (ja) * 2009-12-07 2015-07-22 株式会社シノテスト Ｓｃｃａ２濃度測定によるアレルギー疾患の検査方法
US20110245592A1 (en) * 2010-04-06 2011-10-06 Schoolcraft William B Secretome Profile-Facilitated In Vitro Fertilization
JP5520246B2 (ja) * 2011-02-25 2014-06-11 株式会社ファンケル アトピー性皮膚炎の検査方法
US9804152B1 (en) * 2012-08-15 2017-10-31 The Procter & Gamble Company Human ex vivo skin model and its use in methods of identifying modulators of skin inflammation
JP5775540B2 (ja) * 2013-02-22 2015-09-09 株式会社ファンケル 皮膚の紫外線照射により負荷される紫外線ストレスの評価方法
JP2015042970A (ja) * 2013-07-25 2015-03-05 株式会社ファンケル ガレクチン−７産生抑制剤
JP2015072226A (ja) * 2013-10-03 2015-04-16 住友ベークライト株式会社 検査方法
CN103869079B (zh) * 2014-03-06 2015-12-30 瑞莱生物工程（深圳）有限公司 一种快速定量检测半乳糖凝集素-3的胶体金试纸
GB2535937B (en) 2014-04-29 2017-05-31 Bio-Cancer Treat Int Ltd Arginase I for treating rheumatoid arthritis
JP6397733B2 (ja) * 2014-11-13 2018-09-26 株式会社ファンケル ニキビ肌評価方法
JP6419654B2 (ja) * 2015-06-22 2018-11-07 株式会社ファンケル 発毛の状態及び頭皮の圧縮応力の評価方法
EP3387430A4 (en) * 2015-12-11 2019-08-14 Expression Pathology, Inc. SRM / MRM DOSINGS
JP6835479B2 (ja) * 2016-04-28 2021-02-24 株式会社 資生堂 アトピー性皮膚炎の皮膚局所の重症度及び治療効果の指標
IL265719B2 (en) * 2016-10-25 2024-01-01 Ticure Ltd FABP4 as a therapeutic target in skin diseases
CN110997939A (zh) * 2017-08-16 2020-04-10 免疫医疗有限责任公司 用于治疗特应性皮炎的组合物和方法以及治疗选择
EP3752645A4 (en) 2018-02-14 2022-04-13 Dermtech, Inc. NEW GENE CLASSIFIERS AND THEIR USES IN NON-MELANOMA SKIN CANCERS
EP3812770A4 (en) * 2018-04-19 2022-01-12 The University of Tokyo METHODS AND KIT TO ASSIST IN DIAGNOSIS OF A DISEASE IN A SUBJECT
CA3099275A1 (en) 2018-05-09 2019-11-14 Dermtech, Inc. Novel gene classifiers and uses thereof in autoimmune diseases
WO2019224200A1 (en) * 2018-05-22 2019-11-28 N.V. Nutricia Biomarkers for improving nutrion for infants at risk
US11578373B2 (en) 2019-03-26 2023-02-14 Dermtech, Inc. Gene classifiers and uses thereof in skin cancers
KR102424960B1 (ko) 2020-08-21 2022-07-25 주식회사 프로라젠 아토피피부염의 신규 바이오마커
WO2022114201A1 (ja) * 2020-11-30 2022-06-02 花王株式会社 アトピー性皮膚炎の症度変化の検出方法
WO2024075844A1 (ja) * 2022-10-07 2024-04-11 株式会社ナノエッグ 炎症性皮膚疾患の検出及び重症度の判定方法
WO2024105449A1 (en) * 2022-11-15 2024-05-23 Shaperon Inc. Biomarkers for predicting the treatment efficacy of gpcr19 agonists in the treatment of atopic dermatitis and methods for treating subjects with such biomarkers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180743A1 (en) 2000-03-02 2003-09-25 Takeshi Nagasu Method of examining allergic diseases
WO2003076658A2 (en) * 2002-03-08 2003-09-18 Decode Genetics Ehf. A susceptibility gene for late-onset idiopathic parkinson's disease
DE602004028933D1 (de) * 2003-05-30 2010-10-14 Univ Illinois Genexpressionsprofile zur identifizierung von genetisch bevorzugten huftieren
WO2005003766A2 (en) * 2003-06-13 2005-01-13 Whitehead Institute For Biomedical Research Methods of regulating metabolism and mitochondrial function
JP2005110602A (ja) 2003-10-09 2005-04-28 Sumitomo Pharmaceut Co Ltd アトピー性皮膚炎の疾患マーカー及びその利用
WO2005045034A2 (en) * 2003-10-23 2005-05-19 Sirna Therapeutics, Inc. RNA INTERFERENCE MEDIATED TREATMENT OF PARKINSON DISEASE USING SHORT INTERERING NUCLEIC ACID (siNA)
DE10361259A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
DE102004004924B4 (de) * 2004-01-27 2007-04-26 Eberhard-Karls-Universität Tübingen Universitätsklinikum A141S-und G399S-Mutation im Omi/HtrA2-Protein bei Morbus Parkinson

Also Published As

Publication number Publication date
KR20080063326A (ko) 2008-07-03
CN103149368B (zh) 2015-06-10
CN103149368A (zh) 2013-06-12
US7820396B2 (en) 2010-10-26
CN103149367A (zh) 2013-06-12
CN103175972B (zh) 2015-05-20
CN103175972A (zh) 2013-06-26
JPWO2007046463A1 (ja) 2009-04-23
HK1182770A1 (zh) 2013-12-06
CN101292032A (zh) 2008-10-22
HK1182769A1 (zh) 2013-12-06
CN103278641A (zh) 2013-09-04
WO2007046463A1 (ja) 2007-04-26
CN103149367B (zh) 2015-04-01
US20090263792A1 (en) 2009-10-22
JP5282228B2 (ja) 2013-09-04

Similar Documents

Publication Publication Date Title
HK1182769A1 (zh) 特應性皮炎標記物及其利用技術
EP2155039A4 (en) MARKER SYSTEMS AND METHOD FOR THEIR USE
EP2055100A4 (en) METHOD FOR CONTROLLING A RECEIVER AND THEREIN USED RECEIVER
HK1120160A1 (en) Trenched-gate field effect transistors and methods of forming the same
EP2232003A4 (en) BRECHFLUIDE AND USE METHOD THEREFOR
IL188680A0 (en) Microfluidic devices and methods of preparing and using the same
EP2070760A4 (en) VEHICLE AND METHOD FOR CONTROLLING THE SAME
EP2209625A4 (en) ARTICLE AND MANUFACTURING METHOD THEREFOR
EP2331155A4 (en) BIOCOMPOSITES AND METHODS OF MAKING THEM
GB0718972D0 (en) Compounds and methods of making the compounds
EP1883389A4 (en) LOW IRRITANT COMPOSITIONS AND METHODS OF MAKING SAME
EP1987397A4 (en) APPARATUS AND METHODS OF WRITING
EP2178094A4 (en) SWITCHING CONNECTING MATERIAL AND CONNECTING STRUCTURE OF A SWITCHING ELEMENT AND CONNECTION METHOD OF A SWITCHING ELEMENT ON THE SWITCHING CONNECTING MATERIAL
PT1973950E (pt) Anticorpos anti-epbh4 e métodos que os utilizam
SI2064327T1 (sl) DBAIT in njegova uporaba
TWI319089B (en) Probe block and probe assembly including the same
EP1943875A4 (en) HEADPHONES AND METHOD OF USE
EP1948828A4 (en) MULTIMEDICAL BIOSENSORS AND METHOD FOR THEIR USE
IL185966A0 (en) Phytoplankton-based nutraceuticals and method of obtaining the same
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
EP2058200A4 (en) VEHICLE AND CONTROL PROCESS THEREFOR
HK1133552A1 (zh) 碳硼烷基卟啉及其用途
EP1859826A4 (en) CONTRAST REMOVAL SYSTEM AND METHOD FOR ACTIVATING THE CONTRAST REMOVAL SYSTEM
EP1850130A4 (en) GENMARKER AND ITS USE
IL195430A0 (en) Arylsulfonamidyl tetralin derivatives and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211021